| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/29/2004 | US20040146514 Cancer therapy using multiple antibodies from different species directed against the tumor3 |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146512 Administering monoclonal antibodies to treat Down syndrome |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146507 Antibody mutants |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146502 Use of organic compounds |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | CA2513025A1 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512729A1 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 07/29/2004 | CA2512717A1 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2511659A1 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | CA2482850A1 A method for the evaluation of hair-growth promoting activity |
| 07/28/2004 | EP1441010A1 Fluorinated xanthene derivatives |
| 07/28/2004 | EP1440978A1 Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods |
| 07/28/2004 | EP1440152A2 5t4 ligand |
| 07/28/2004 | EP1440150A2 Pyranosone dehydratase from phanerochaete chrysosporium |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1440086A1 Infectious salmon anaemia virus vaccine |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1439857A2 Use of bispecific antibodies to regulate immune responses |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP0981651B1 Detection of retroviral subtypes based upon envelope specific sequences |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/27/2004 | US6768004 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1F7, an anti-idiotypic antibody reactive with anti-HIV antibodies |
| 07/27/2004 | US6768001 Xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
| 07/27/2004 | US6767997 Antibodies that bind deoxyribonuclease IIβ enzyme proteins |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767995 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2004 | US6767742 Antibody-mediated down-regulation of plant proteins |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767541 HER-2/neu overexpression abrogates growth inhibitory pathways |
| 07/27/2004 | US6767540 Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061104A2 Method for manufacturing recombinant polyclonal proteins |
| 07/22/2004 | WO2004061079A2 Candida kefyr cytosine deaminase |
| 07/22/2004 | WO2004061075A2 Target recognizing binding agents |
| 07/22/2004 | WO2004060919A1 Agonist antibody against heteroreceptor |
| 07/22/2004 | WO2004060918A1 Detecting lipocalin |
| 07/22/2004 | WO2004060911A2 Combination therapy with co-stimulatory factors |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060295A2 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | WO2004060291A2 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060041A2 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | WO2004040398A9 Use of a computer to design a molecule |
| 07/22/2004 | WO2004037861A3 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/22/2004 | WO2004029214A8 Lfa-1 alpha subunit antibodies and methods of use |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004019861A3 Stable ph optimized formulation of a modified antibody |
| 07/22/2004 | WO2004019860A3 Formulations of modified antibodies and methods of making the same |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2003106695A3 Methods and compositions for in vivo clearance of pathogens |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003073916A3 Immune regulation |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003028668A3 Gammaglobulin treatment of immune disorders |
| 07/22/2004 | WO2003024302A3 Detection and treatment of cancers of breast |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143858 Protein associated with phagocytic cells for use as tools in characterizing immune response |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143101 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 07/22/2004 | US20040143100 High affinity humanized monoclonal antibodies |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143094 Multicomponent conjugates which bind to target molecules and stimulate T cell lysis |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142872 Polyamine modified antibodies having specific binding affinity for A beta also have increased permeability at the blood-brain barrier and can be used for passive immunization and treatment of Altzheimer's disease |
| 07/22/2004 | US20040142871 Osteoporosis treatment |
| 07/22/2004 | US20040142455 Recombinant botulinum toxins having a soluble C-terminal portion of a heavy chain, an N-terminal portion of a heavy chain and a light chain |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142430 Production of a multimeric protein by cell fusion method |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142400 High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody |
| 07/22/2004 | US20040142396 Methods and compositions for diagnosing carcinomas |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142389 Immunoglobulin which specifically binds gastrointestinal tract (GIT) transport receptors for use as tools in tissue targeted therapies; drug screening and delivery |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142382 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement |
| 07/22/2004 | US20040142376 Deoxyribonuclease IIbeta proteins and cDNAs |
| 07/22/2004 | US20040142372 Comprises nucleotide sequences coding cytokine binding protein for use in identifying modulators for treatment of cell proliferative and inflammatory disorders |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |